Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Elon Musk's Pivot to X Draws Strong Opinions Across Twitter
Business

Elon Musk's Pivot to X Draws Strong Opinions Across Twitter

The latest move by the billionaire owner to remake the platform elicits excitement and dismay from users, shrugs from advertisers. Source link

Here Come the Family EVs
Business

Here Come the Family EVs

What to Read Next Source link

Threads User Engagement Continues to Decline
Business

Threads User Engagement Continues to Decline

User engagement has fallen 70%, putting pressure on parent Meta to roll out new features for its nascent microblogging app. Source link

Sergey Brin Is Back in the Trenches at Google
Business

Sergey Brin Is Back in the Trenches at Google

Co-founder is working alongside AI researchers at tech giant’s headquarters, aiding efforts to build powerful Gemini system. Source link

United Airlines Scaling Back Flights at Newark Airport
Business

United Airlines Scaling Back Flights at Newark Airport

The carrier is reassessing Newark, N.J., operations after June flight cancellations, while United and American boosted their profit forecasts as summer travel booms. Source link

Macy’s Wants Your Size 8 Dress to Fit Like One
Business

Macy's Launches New Brand Promising Better-Fitting Clothes

The department-store chain tackles the problem of inconsistent sizing with new private-label brand, On 34th. Source link

Microsoft Shows AI Won't Be a Loss Leader
Finances

Microsoft Shows AI Won't Be a Loss Leader

The software company’s pricing of its Copilot AI tool came in well above projections. Source link

Meta, Microsoft Team Up to Offer New AI Software for Businesses
Business

Meta, Microsoft Team Up to Offer New AI Software for Businesses

The Meta AI model, dubbed Llama 2, will be free and available to developers building software on Microsoft’s Azure cloud-computing platform. Source link

FDA Approves First RSV Drug to Protect All Infants
Business

FDA Approves First RSV Drug to Protect All Infants

While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link